Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harold R Collard

Showing results (121-130 of 213) with videos related to

Pageof 22
Sort By:
Annals of the American Thoracic Society|March 30, 2017
Code-based Diagnostic Algorithms for Idiopathic Pulmonary Fibrosis. Case Validation and ImprovementBrett Ley, Thomas Urbania, Gail Husson, et al.
American Journal of Respiratory and Critical Care Medicine|November 20, 2018
Closing the Evidence Gap in Interstitial Lung Disease. The Promise of Real-World DataErica Farrand, Kevin J Anstrom, Gordon Bernard, et al.
Chest|October 14, 2008
Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of responseAlicia Ferreira, Chris Garvey, Gerilynn L Connors, et al.
American Journal of Respiratory and Critical Care Medicine|November 28, 2017
Identification of Diagnostic Criteria for Chronic Hypersensitivity Pneumonitis: An International Modified Delphi SurveyJulie Morisset, Kerri A Johannson, Kirk D Jones, et al.
Thorax|December 24, 2021
Relative environmental and social disadvantage in patients with idiopathic pulmonary fibrosisNa'ama Avitzur, Elizabeth M Noth, Mubasiru Lamidi, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|September 2, 2015
Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?Sergio Harari, Marc Humbert, Francesco Blasi, et al.
Respirology (Carlton, Vic.)|January 7, 2012
Depression is a common and chronic comorbidity in patients with interstitial lung diseaseChristopher J Ryerson, Patricia A Arean, Jane Berkeley, et al.
The European Respiratory Journal|November 2, 2013
Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposureKerri A Johannson, Eric Vittinghoff, Kiyoung Lee, et al.
Chest|June 11, 2004
Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosisHarold R Collard, Jay H Ryu, William W Douglas, et al.
The Lancet. Respiratory Medicine|January 17, 2014
Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trialsJoyce S Lee, Harold R Collard, Kevin J Anstrom, et al.
Pageof 22

Showing results (121-130 of 213) with videos related to

Sort By:
Pageof 22
Annals of the American Thoracic Society|March 30, 2017
Code-based Diagnostic Algorithms for Idiopathic Pulmonary Fibrosis. Case Validation and ImprovementBrett Ley, Thomas Urbania, Gail Husson, et al.
American Journal of Respiratory and Critical Care Medicine|November 20, 2018
Closing the Evidence Gap in Interstitial Lung Disease. The Promise of Real-World DataErica Farrand, Kevin J Anstrom, Gordon Bernard, et al.
Chest|October 14, 2008
Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of responseAlicia Ferreira, Chris Garvey, Gerilynn L Connors, et al.
American Journal of Respiratory and Critical Care Medicine|November 28, 2017
Identification of Diagnostic Criteria for Chronic Hypersensitivity Pneumonitis: An International Modified Delphi SurveyJulie Morisset, Kerri A Johannson, Kirk D Jones, et al.
Thorax|December 24, 2021
Relative environmental and social disadvantage in patients with idiopathic pulmonary fibrosisNa'ama Avitzur, Elizabeth M Noth, Mubasiru Lamidi, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|September 2, 2015
Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?Sergio Harari, Marc Humbert, Francesco Blasi, et al.
Respirology (Carlton, Vic.)|January 7, 2012
Depression is a common and chronic comorbidity in patients with interstitial lung diseaseChristopher J Ryerson, Patricia A Arean, Jane Berkeley, et al.
The European Respiratory Journal|November 2, 2013
Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposureKerri A Johannson, Eric Vittinghoff, Kiyoung Lee, et al.
Chest|June 11, 2004
Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosisHarold R Collard, Jay H Ryu, William W Douglas, et al.
The Lancet. Respiratory Medicine|January 17, 2014
Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trialsJoyce S Lee, Harold R Collard, Kevin J Anstrom, et al.
Pageof 22